TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02681471 — Surrogate Endpoint (SUR): Serum sodium
Study NCT02681471 — Surrogate Endpoint (SUR): Serum potassium
Study NCT03119428 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT03119428 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT04846283 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04846283 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04846283 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04846283 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT00958542 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00343551 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02722746 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04406558 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03940300 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01022138 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02588404 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT04021342 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04158375 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT03206801 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT03758534 — Predictive Biomarker (PRD): ENPP1 mRNA
Genes: ENPP1; M6S1; NPPS; PC1; PDNP1
Study NCT03758534 — Predictive Biomarker (PRD): ABCC6 mRNA
Genes: ABCC6; ARA; MRP6
Study NCT04468841 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT02175940 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02175940 — Predictive Biomarker (PRD): SERPINF1 mRNA
Genes: SERPINF1; PEDF; PIG35
Study NCT02175940 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04791618 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02411019 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03117985 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02507388 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03437499 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study NCT04481048 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT01443039 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT01443039 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01443039 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT01443039 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01443039 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03933761 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03933761 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT05542654 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00186121 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01673204 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01673204 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04307823 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02076152 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01548066 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT02777489 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study NCT00759551 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00559221 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05610228 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05610228 — Predictive Biomarker (PRD): HLF mRNA
Genes: HLF
Study NCT05610228 — Predictive Biomarker (PRD): Induced myeloid leukemia cell differentiation protein Mcl-1
Genes: MCL1; BCL2L3
Study NCT05610228 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT01722552 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03984916 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03538639 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00250887 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00250887 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01572727 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01572727 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04556708 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04556708 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01274338 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT03027349 — Surrogate Endpoint (SUR): Serum calcium
Study NCT03872349 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study NCT01262066 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02717052 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study NCT02025777 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04313634 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01591187 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04653194 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02797925 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02797925 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01487265 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01487265 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00396266 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04492501 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT04492501 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02227667 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00549926 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00169611 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT00265317 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00265317 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00265317 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT00265317 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06784739 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03306719 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT06785077 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT06785077 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT06785077 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A
Study NCT06785077 — Predictive Biomarker (PRD): ASXL1 mRNA
Genes: ASXL1; KIAA0978
Study NCT06785077 — Predictive Biomarker (PRD): TET2 mRNA
Genes: TET2; KIAA1546; Nbla00191
Study NCT06785077 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT02607774 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03776331 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04028804 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT02656004 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04367246 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT01415141 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study NCT02390596 — Safety Biomarker (SAF): Interleukin 1
Study NCT00571038 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03634930 — Predictive Biomarker (PRD): PTPRU mRNA
Genes: PTPRU; FMI; PCP2; PTPRO
Study NCT00481351 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03937895 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00101166 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00002176 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02438111 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study NCT02438111 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT02438111 — Predictive Biomarker (PRD): PLEKHA1 mRNA
Genes: PLEKHA1; TAPP1
Study NCT02438111 — Predictive Biomarker (PRD): HTRA1 mRNA
Genes: HTRA1; HTRA; PRSS11
Study NCT02438111 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02438111 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT04144257 — Predictive Biomarker (PRD): NE
Study NCT04050293 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study NCT01425125 — Surrogate Endpoint (SUR): Serum sodium
Study NCT04287387 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01781572 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT00157326 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01709370 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00780494 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03792256 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study NCT03792256 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03792256 — Predictive Biomarker (PRD): CDK6 mRNA
Genes: CDK6; CDKN6
Study NCT02879825 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study NCT04014985 — Predictive Biomarker (PRD): MECP2 mRNA
Genes: MECP2
Study NCT01156103 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02848534 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02848534 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT02848534 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT02848534 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04475120 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04475120 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02804581 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04290000 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05099458 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00149227 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04195243 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT00752479 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03124576 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study NCT01979952 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00153764 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02496013 — Predictive Biomarker (PRD): NEB mRNA
Genes: NEB
Study NCT04830449 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00317772 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04557813 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT04557813 — Predictive Biomarker (PRD): NTRK2 mRNA
Genes: NTRK2; TRKB
Study NCT04557813 — Predictive Biomarker (PRD): NTRK3 mRNA
Genes: NTRK3; TRKC
Study NCT03215095 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03959865 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00445172 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00584519 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01730443 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT00235885 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01094158 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00653588 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01407757 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT00907504 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT02624453 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06785493 — Predictive Biomarker (PRD): UST mRNA
Genes: UST; DS2ST
Study NCT00917761 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02652351 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00628680 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT04355546 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study NCT01804881 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02316496 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02316496 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT01770171 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00377819 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01278277 — Predictive Biomarker (PRD): ABCA4 mRNA
Genes: ABCA4; ABCR
Study NCT01724021 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02903121 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT02903121 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00019331 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00019331 — Pharmacodynamic Biomarker (PDY): RAS peptides
Study NCT00019331 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01504594 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01714765 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02624973 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02624973 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT02624973 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study NCT02624973 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study NCT02624973 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00055692 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04616625 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01230697 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT02220036 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01870505 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01870505 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02069808 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02370602 — Predictive Biomarker (PRD): PDE10A mRNA
Genes: PDE10A
Study NCT04426721 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02852304 — Predictive Biomarker (PRD): LIPA mRNA
Genes: LIPA
Study NCT02949544 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06784713 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04422379 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03432624 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03402035 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02343406 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03563716 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT03563716 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03563716 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00308971 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00308971 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00175682 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00319254 — Predictive Biomarker (PRD): SKI mRNA
Genes: SKI
Study NCT02436538 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00555217 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02972684 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00819871 — Predictive Biomarker (PRD): NFKB1 mRNA
Genes: NFKB1
Study NCT01876173 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04046224 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT04759105 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04499794 — Predictive Biomarker (PRD): EML4 mRNA
Genes: EML4; C2orf2; EMAPL4
Study NCT04499794 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00246857 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00794950 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03793478 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT00353600 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00353600 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00353600 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03709134 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04206306 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study NCT04206306 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT02220608 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03455972 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03455972 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT01840566 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04755751 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT05709730 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00861705 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00861705 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00516126 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT02521090 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02521090 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00728468 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT04102423 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00826618 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00826618 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03816358 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT04293419 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04506073 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03449381 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT03660969 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT02048501 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT02311933 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02311933 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03135054 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT03181399 — Monitoring Biomarker (MOI): Complement C7
Genes: C7
Study NCT03319823 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03800134 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT02450656 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02450656 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT02134340 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study NCT00830479 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04288726 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT01607944 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00852787 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00347009 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02015013 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02015013 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02015013 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT02015013 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT02015013 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study NCT00729612 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03550508 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT04523207 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04523207 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01821664 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01310036 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01310036 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04482309 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL